Risk factors for a severe disease course in children with SARS-COV-2 infection following hematopoietic cell transplantation in the pre-Omicron period: a prospective multinational Infectious Disease Working Party from the European Society for Blood and Marrow Transplantation group (EBMT) and the Spanish Group of Hematopoietic Stem Cell Transplantation (GETH) study.

Autor: Averbuch D; Faculty of Medicine, Hebrew University of Jerusalem, Pediatric Infectious Diseases, Hadassah Medical Center, Jerusalem, Israel. adiana@hadassah.org.il., de la Camara R; Hematology Department, Hospital Universitario de La Princesa, Madrid, Spain., Tridello G; Pediatric Hematology Oncology, Department of Mother and Child, Azienda Ospedaliera Universitaria Integrata, Verona, Italy., Knelange NS; EBMT - Leiden Study Unit, Leiden, Netherlands., Bykova TA; RM Gorbacheva Research Institute, Pavlov University, St. Petersburg, Russia., Ifversen M; Department of Children and Adolescents Medicine, Stem Cell Transplant Unit, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Dobsinska V; Department of Pediatric Hematology and Oncology, Comenius University, Bratislava, Slovakia.; Bone Marrow Transplantation Unit, National Institute of Children's Diseases, Bratislava, Slovakia., Ayas M; Pediatric Hematology/Oncology, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia., Hamidieh AA; Pediatric Cell and Gene Therapy Research Center, Gene, Cell & Tissue Research Institute, Tehran University of Medical Sciences, Tehran, Iran., Pichler H; Department of Pediatric Hematology and Oncology, St. Anna Children's Hospital, Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria., Perez-Martinez A; Department of Pediatric Hematology and Oncology, Hospital Universitario La Paz, Madrid, Spain., Cesaro S; Pediatric Hematology Oncology, Department of Mother and Child, Azienda Ospedaliera Universitaria Integrata, Verona, Italy., Sundin M; Section of Pediatric Hematology, Immunology and HCT, Astrid Lindgren Children's Hospital, Karolinska University Hospital and Division of Pediatrics, CLINTEC, Karolinska Institutet, Stockholm, Sweden., Badell I; Pediatric BMT Unit, Hospital Santa Creu i Sant Pau, Universitat Autonoma de Barcelona, Barcelona, Spain., Bader P; Universitaetsklinikum Frankfurt Goethe-Universitaet, Frankfurt Main, Germany., Johansson JE; Sahlgrenska University Hospital, Goeteborg, Sweden., Mirci-Danicar O; BMT Unit, Bristol Royal Hospital for Children, Bristol, UK., Sedlacek P; HSCT Unit, Department of Paediatric Haematology and Oncology, University Hospital Motol, Prague, Czech Republic., Paillard C; Pediatric Hematology Oncology, Hautepierre Hospital, Strasbourg University, Strasbourg, France., Gibson B; Department of Haematology, Royal Hospital for Children, Glasgow, UK., Lawson S; Department of Haematology, Birmingham Children's Hospital, Birmingham, UK., Kroeger N; Department of Stem Cell Transplantation, University Hospital Eppendorf, Hamburg, Germany., Corbacioglu S; Department of Pediatric Hematology, Oncology and Stem Cell Transplantation, University of Regensburg, Regensburg, Germany., Mikulska M; Division of Infectious Diseases, University of Genova, Ospedale Policlinco San Martino, Genova, Italy., Piñana JL; Hospital Clinico Universitario de Valencia. Fundación de investigación INCLIVA, Hospital Clinico Universitario de Valencia, Valencia, Spain., Styczynski J; Pediatric Hematology and Oncology, University Hospital, Collegium Medicum, Nicolaus Copernicus University Torun, Bydgoszcz, Poland., Ljungman P; Department of Cellular Therapy and Allogeneic Stem Cell Transplantation, Karolinska Comprehensive Cancer Center, Karolinska University Hospital Huddinge, Division of Hematology, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden.

Publikováno v: Bone marrow transplantation [Bone Marrow Transplant] 2023 May; Vol. 58 (5), pp. 558-566. Date of Electronic Publication: 2023 Feb 27.

Comparison of autologous and allogeneic hematopoietic cell transplantation strategies in patients with primary plasma cell leukemia, with dynamic prediction modeling.

Autor: Lawless S; Belfast City Hospital, Belfast., Iacobelli S; Tor Vergata University, Rome., Knelange NS; EBMT Data Office Leiden, Leiden., Chevallier P; CHU Nantes, Nantes., Blaise D; ICRCM, INSERM, CNRS, AMU and Institut Paoli Calmettes, Marseille., Milpied N; CHU Bordeaux, Pessac., Foà R; Univ.`La Sapienza`, Rome., Cornelissen JJ; Erasmus MC Cancer Institute, Rotterdam., Lioure B; Nouvel Hopital Civil, Strasbourg., Benjamin R; Kings College Hospital, London., Poiré X; Cliniques Universitaires St. Luc, Brussels., Minnema MC; University Medical Center, Utrecht, Utrecht., Collin M; Freeman Hospital, Newcastle., Lenhoff S; Skanes University Hospital, Lund., Snowden JA; Sheffield Teaching Hospitals Foundation Trust, Sheffield., Santarone S; Ospedale Civile, Pescara., Wilson KMO; University Hospital of Wales, Cardiff Wales., Trigo F; Hospital Sao Joao, Porto., Dreger P; University of Heidelberg, Heidelberg., Böhmer LH; Haga Teaching Hospital The Hague., Putter H; Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden., Garderet L; Hospital Saint Antoine, Paris., Kröger N; University Hospital Eppendorf, Hamburg., Yaukoub-Agha I; CHU de Lille, Univ Lille, INSERM U1286, Infinite, 59000 Lille, Lille., Schönland S; University of Heidelberg, Heidelberg. Stefan.Schoenland@med.uni-heidelberg.de., Morris C; Queens University of Belfast, Belfast.

Publikováno v: Haematologica [Haematologica] 2023 Apr 01; Vol. 108 (4), pp. 1105-1114. Date of Electronic Publication: 2023 Apr 01.

Impact of early candidemia on the long-term outcome of allogeneic hematopoietic stem cell transplant in non-leukemic patients: an outcome analysis on behalf of IDWP-EBMT.

Autor: Cesaro S; Azienda Ospedaliera Universitaria Integrata Verona, Verona, Italy. simone.cesaro@aovr.veneto.it., Tridello G; Azienda Ospedaliera Universitaria Integrata Verona, Verona, Italy., Knelange NS; EBMT Data Office, Leiden, Netherlands., Blijlevens N; Radboud University Medical Centre, Nijmegen, Netherlands., Martin M; Leicester Royal Infirmary, Leicester, UK., Snowden JA; Department of Haematology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK., Malladi R; University Hospital Birmingham NHS Trust, Birmingham, UK., Ljungman P; Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden., Deconinck E; Hopital Jean Minjoz, Besancon, France., Gedde-Dahl T; Oslo University Hospital, Rikshospitalet, Oslo, Norway., Byrne J; Nottingham University Hospital NHS Trust, Nottingham, UK., Xhaard A; Hopital St. Louis, Paris, France., Chevallier P; Dept.D'Hematologie, CHU Nantes, Nantes, France., Maertens J; University Hospital Gasthuisberg, Leuven, Belgium., Zuckerman T; Rambam Medical Center, Haifa, Israel., Lioure B; Techniciens d'Etude Clinique suivi de patients greffes, Strasbourg, France., Petersen E; University Medical Centre Regensburg, Utrecht, Netherlands., Cornelissen JJ; Erasmus MC Cancer Institute, Rotterdam, Netherlands., Arcese W; Hematopoietic Stem cell Transplant Unit, Tor Vergata University of Rome, Rome, Italy., Blaise D; Programme de Transplantation &Therapie Cellulaire, Marseille, France., Milpied N; CHU Bordeaux, Pessac, France., Cahn JY; CHU Grenoble Alpes-Université Grenoble Alpes, Grenoble, France., Aljurf M; King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia., de Wreede L; Dept of Biomedical Data Sciences, LUMC, Leiden, Netherlands., Mauro M; Azienda Ospedaliera Universitaria Integrata Verona, Verona, Italy., de la Camara R; Hospital de la Princesa, Madrid, Spain., Averbuch D; 5Pediatric Infectious Diseases, Hadassah University Hospital, Jerusalem, Israel., Mikulska M; Stem Cell Transplant Unit, Ospedale San Martino, Genova, Italy., Styczynski J; Department of Pediatric Hematology and Oncology, Collegium Medicum UMK Torun, Bydgoszcz, Poland.

Publikováno v: Bone marrow transplantation [Bone Marrow Transplant] 2021 Jul; Vol. 56 (7), pp. 1563-1572. Date of Electronic Publication: 2021 Jan 29.

Long-term outcome after allogeneic hematopoietic cell transplantation for myelofibrosis.

Autor: Robin M; Hôpital Saint-Louis, APHP, Université Paris 7, Paris, France marie.robin@aphp.fr., de Wreede LC; Department of Biomedical Data Sciences, LUMC, Leiden, the Netherlands and DKMS CTU, Dresden, Germany., Wolschke C; University Hospital Eppendorf, Hamburg, Germany., Schetelig J; Medizinische Klinik und Poliklinik I, Universitätsklinikum Dresden, Dresden, Germany., Eikema DJ; EBMT Statistical Unit, Leiden, the Netherlands., Van Lint MT; Ospedale San Martino, Genova, Italy., Knelange NS; EBMT Data Office, Leiden, the Netherlands., Beelen D; University Hospital, Essen, Germany., Brecht A; Helios HSK Wiesbaden, Wiesbaden, Germany., Niederwieser D; University Hospital Leipzig, Leipzig, Germany., Vitek A; Institute of Hematology and Blood Transfusion, Prague, Czech Republic., Bethge W; Universität Tübingen, Tübingen, Germany., Arnold R; Charité Universitätsmedizin Berlin, Berlin, Germany., Finke J; Division of Medicine I, Hematology, Oncology and Stem Cell Transplantation, University of Freiburg, Freiburg, Germany., Volin L; HUCH Comprehensive Cancer Center, Helsinki, Finland., Yakoub-Agha I; CHU de Lille, INSERM U995, Lille, France., Nagler A; Chaim Sheba Medical Center, Tel-Hashomer, Israel., Poiré X; Cliniques Universitaires St. Luc, Brussels, Belgium., Einsele H; Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany., Chevallier P; CHU Nantes, Nantes, France., Holler E; University Regensburg, Regensburg, Germany., Ljungman P; Karolinska University Hospital, Stockholm, Sweden., Robinson S; Bristol Oncology Centre, Bristol, UK., Radujkovic A; University of Heidelberg, Heidelberg, Germany., McLornan D; Comprehensive Cancer Centre, Department of Haematology, Kings College, London, UK., Chalandon Y; Hôpitaux Universitaires de Genève and Faculty of Medicine, University of Geneva, Geneva, Switzerland., Kröger N; University Hospital Eppendorf, Hamburg, Germany.

Publikováno v: Haematologica [Haematologica] 2019 Sep; Vol. 104 (9), pp. 1782-1788. Date of Electronic Publication: 2019 Feb 07.

Outcomes of Haploidentical Transplantation in Patients with Relapsed Multiple Myeloma: An EBMT/CIBMTR Report.

Autor: Sahebi F; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope Medical Center, Duarte, California; Southern California Kaiser Permanente Medical Group, Los Angeles, California. Electronic address: fsahebi@coh.org., Garderet L; Department of Hematology and Cellular Therapy, Hospital Saint Antoine, Paris, France., Kanate AS; Department of Medicine, West Virginia University, Morgantown, West Virginia., Eikema DJ; European Society for Blood and Marrow Transplantation Statistical Unit, Leiden, The Netherlands., Knelange NS; European Society for Blood and Marrow Transplantation Data Office, Leiden, The Netherlands., Alvelo OFD; Center for International Blood and Marrow Transplant Research, Milwaukee Campus, Milwaukee, Wisconsin., Koc Y; Stem Cell Transplantation Unit, Medical Park Hospitals, Antalya, Turkey., Blaise D; Department of Hematology, Centre de Recherche en Cancérologie de Marseille, Marseille, France., Bashir Q; Department of Stem Cell Transplantation and Cellular, Therapy The University of Texas MD Anderson Cancer Center, Houston, Texas., Moraleda JM; Unidad de Terapia Celular, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain., Dreger P; Department of Medicine, University of Heidelberg, Heidelberg, Germany., Sanchez JF; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope Medical Center, Duarte, California., Ciurea S; Department of Stem Cell Transplantation and Cellular, Therapy The University of Texas MD Anderson Cancer Center, Houston, Texas., Schouten H; Department of Hematology, University Hospital Maastricht, Maastricht, The Netherlands., Shah NN; Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin., Verbeek M; Allogene und autologe Stammzelltransplantation, Klinikum Rechts der Isar, Munich, Germany., Rösler W; Department of Hematology and Oncology, University Hospital Erlangen, Erlangen, Germany., Diez-Martin JL; Department of Hematology, Hospital Gregorio Marañón, Madrid, Spain., Schoenland S; Department of Medicine, University of Heidelberg, Heidelberg, Germany., D'Souza A; Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin., Kröger N; Department of Stem Cell Transplantation, University Hospital, Eppendorf, Germany., Hari P; Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin.

Publikováno v: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation [Biol Blood Marrow Transplant] 2019 Feb; Vol. 25 (2), pp. 335-342. Date of Electronic Publication: 2018 Sep 20.